| PS | Pathological Scars |
| TRP | Transient Receptor Potential |
| KC | Keratinocyte |
| FB | Fibroblast |
| MFB | Myofibroblast |
| ECM | Extracellular Matrix |
| HS | Hypertrophic Scar |
| IL | Interleukin |
| TGF-β1 | Transforming Growth Factor-Beta 1 |
| TNF-α | Tumor Necrosis Factor-Alpha |
| TSLP | Thymic Stromal Lymphopoietin |
| SP | Substance P |
| CGRP | Calcitonin Gene-Related Peptide |
| NF-κB | Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells |
| MAPK | Mitogen-Activated Protein Kinase |
| PI3K | Phosphoinositide 3-Kinase |
| AKT | Protein Kinase B |
| ERK | Extracellular Signal-Regulated Kinase |
| JAK | Janus Kinase |
| STAT | Signal Transducer and Activator of Transcription |
| Smad | Mothers Against Decapentaplegic Homolog |
| NFAT | Nuclear Factor of Activated T-cells |
| YAP | Yes-Associated Protein |
| TAZ | Transcriptional Co-activator with PDZ-Binding Motif |
| PAR2 | Protease-Activated Receptor 2 |
| EDNRB | Endothelin Receptor Type B |
| ET-1 | Endothelin-1 |
| Ca2+ | Calcium Ion |
| α-SMA | Alpha-Smooth Muscle Actin |
| COL-1 | Collagen Type I |
| COL-3 | Collagen Type III |
| ILC2 | Group 2 Innate Lymphoid Cells |
| EMT | Epithelial-Mesenchymal Transition |
| RCT | Randomized Controlled Trial |
| AI | Artificial Intelligence |